Microbix Biosystms(TSE:MBX)
CA$0.30+0.02 (+7.27%)
TSE:MBX
Microbix Biosystms financials statements
CA$0.30
At close:+0.02 (+7.27%)
Want to see TSE:MBX full AI Analyst Report?
Microbix Biosystms (MBX) Ratios
39 Followers
Microbix Biosystms Ratios
TSE:MBX's free cash flow for Q3 2026 was C$-514.68K. For the 2026 fiscal year, TSE:MBX's free cash flow was decreased by C$-47.87K and operating cash flow was C$-466.81K. See a summary of the company’s cash flow.
| Ratios | Sep 25 | Sep 24 | Sep 23 | Sep 22 | Sep 21 |
|---|---|---|---|---|---|
| Liquidity Ratios | |||||
| Current Ratio | 8.48 | 7.15 | 5.13 | 8.45 | 3.68 |
| Quick Ratio | 5.17 | 5.24 | 3.80 | 6.46 | 2.83 |
| Cash Ratio | 4.36 | 3.82 | 2.67 | 5.09 | 1.92 |
| Solvency Ratio | -0.05 | 0.52 | 0.10 | 0.34 | 0.24 |
| Operating Cash Flow Ratio | -0.03 | 1.28 | -0.25 | 1.31 | 0.41 |
| Short-Term Operating Cash Flow Coverage | 0.00 | 39.13 | -9.85 | 31.18 | 0.86 |
| Net Current Asset Value | C$ 13.95M | C$ 14.46M | C$ 11.27M | C$ 14.20M | C$ 8.82M |
| Leverage Ratios | |||||
| Debt-to-Assets Ratio | 0.18 | 0.17 | 0.19 | 0.18 | 0.27 |
| Debt-to-Equity Ratio | 0.24 | 0.23 | 0.27 | 0.23 | 0.42 |
| Debt-to-Capital Ratio | 0.20 | 0.18 | 0.21 | 0.19 | 0.29 |
| Long-Term Debt-to-Capital Ratio | 0.16 | 0.16 | 0.19 | 0.16 | 0.18 |
| Financial Leverage Ratio | 1.35 | 1.35 | 1.45 | 1.33 | 1.55 |
| Debt Service Coverage Ratio | 0.51 | 5.86 | 2.06 | 3.89 | 1.00 |
| Interest Coverage Ratio | -1.66 | 4.24 | -3.26 | 3.26 | 3.02 |
| Debt to Market Cap | 0.14 | 0.12 | 0.14 | 0.07 | 0.09 |
| Interest Debt Per Share | 0.06 | 0.05 | 0.05 | 0.05 | 0.08 |
| Net Debt to EBITDA | -12.48 | -1.06 | -2.54 | -2.06 | -0.40 |
| Profitability Margins | |||||
| Gross Profit Margin | 53.02% | 60.61% | 45.30% | 58.32% | 59.40% |
| EBIT Margin | -7.27% | 18.08% | 4.84% | 13.68% | 26.01% |
| EBITDA Margin | 2.30% | 24.44% | 11.85% | 19.55% | 30.43% |
| Operating Profit Margin | -8.48% | 15.38% | -16.57% | 14.11% | 26.01% |
| Pretax Profit Margin | -12.38% | 14.46% | -0.24% | 9.78% | 17.39% |
| Net Profit Margin | -12.08% | 13.86% | -0.24% | 9.38% | 8.77% |
| Continuous Operations Profit Margin | -12.08% | 13.86% | -0.24% | 9.38% | 17.39% |
| Net Income Per EBT | 97.58% | 95.90% | 100.00% | 95.86% | 50.42% |
| EBT Per EBIT | 146.02% | 94.00% | 1.44% | 69.30% | 66.85% |
| Return on Assets (ROA) | -6.00% | 9.24% | -0.11% | 5.40% | 5.65% |
| Return on Equity (ROE) | -8.08% | 12.44% | -0.16% | 7.17% | 8.79% |
| Return on Capital Employed (ROCE) | -4.55% | 11.25% | -8.74% | 8.83% | 20.46% |
| Return on Invested Capital (ROIC) | -4.41% | 10.72% | -8.67% | 8.39% | 9.27% |
| Return on Tangible Assets | -6.67% | 10.39% | -0.13% | 5.65% | 6.00% |
| Earnings Yield | -6.09% | 7.69% | -0.09% | 2.59% | 2.25% |
| Efficiency Ratios | |||||
| Receivables Turnover | 11.54 | 6.06 | 3.95 | 6.18 | 4.42 |
| Payables Turnover | 4.42 | 3.76 | 4.34 | 4.35 | 4.21 |
| Inventory Turnover | 0.95 | 1.55 | 1.57 | 1.50 | 1.71 |
| Fixed Asset Turnover | 1.84 | 2.64 | 1.85 | 2.14 | 2.30 |
| Asset Turnover | 0.50 | 0.67 | 0.46 | 0.58 | 0.64 |
| Working Capital Turnover Ratio | 0.89 | 1.31 | 0.88 | 1.13 | 2.28 |
| Cash Conversion Cycle | 333.36 | 198.95 | 240.65 | 217.77 | 208.88 |
| Days of Sales Outstanding | 31.63 | 60.21 | 92.30 | 59.11 | 82.56 |
| Days of Inventory Outstanding | 384.39 | 235.89 | 232.41 | 242.60 | 213.11 |
| Days of Payables Outstanding | 82.66 | 97.15 | 84.05 | 83.94 | 86.79 |
| Operating Cycle | 416.02 | 296.10 | 324.71 | 301.70 | 295.67 |
| Cash Flow Ratios | |||||
| Operating Cash Flow Per Share | -0.00 | 0.03 | -0.01 | 0.03 | 0.02 |
| Free Cash Flow Per Share | -0.01 | 0.02 | -0.02 | 0.01 | 0.01 |
| Dividend Paid and CapEx Coverage Ratio | -0.10 | 2.28 | -1.08 | 1.71 | 1.62 |
| Capital Expenditure Coverage Ratio | -0.10 | 2.28 | -1.08 | 1.71 | 1.62 |
| Operating Cash Flow Coverage Ratio | -0.01 | 0.68 | -0.16 | 0.60 | 0.27 |
| Operating Cash Flow to Sales Ratio | -0.00 | 0.17 | -0.07 | 0.18 | 0.11 |
| Free Cash Flow Yield | -2.38% | 5.33% | -4.94% | 2.09% | 1.11% |
| Valuation Ratios | |||||
| Price-to-Earnings (P/E) Ratio | -16.46 | 13.01 | -1082.81 | 38.60 | 44.38 |
| Price-to-Sales (P/S) Ratio | 1.98 | 1.80 | 2.59 | 3.62 | 3.89 |
| Price-to-Book (P/B) Ratio | 1.33 | 1.62 | 1.74 | 2.77 | 3.90 |
| Price-to-Free Cash Flow (P/FCF) Ratio | -42.02 | 18.76 | -20.25 | 47.96 | 89.97 |
| Price-to-Operating Cash Flow Ratio | -459.30 | 10.53 | -39.06 | 19.92 | 34.34 |
| Price-to-Earnings Growth (PEG) Ratio | 0.10 | -0.00 | 10.59 | -5.48 | -0.36 |
| Enterprise Value Multiple | 73.63 | 6.32 | 19.31 | 16.46 | 12.39 |
| Enterprise Value | 31.53M | 39.23M | 37.79M | 61.38M | 70.10M |
| EV to EBITDA | 73.63 | 6.32 | 19.31 | 16.46 | 12.39 |
| EV to Sales | 1.70 | 1.54 | 2.29 | 3.22 | 3.77 |
| EV to Free Cash Flow | -35.93 | 16.07 | -17.90 | 42.64 | 87.17 |
| EV to Operating Cash Flow | -392.74 | 9.02 | -34.53 | 17.71 | 33.27 |
| Tangible Book Value Per Share | 0.17 | 0.18 | 0.15 | 0.17 | 0.15 |
| Shareholders’ Equity Per Share | 0.20 | 0.21 | 0.18 | 0.18 | 0.16 |
| Tax and Other Ratios | |||||
| Effective Tax Rate | 0.02 | 0.04 | 0.00 | 0.04 | 0.50 |
| Revenue Per Share | 0.13 | 0.19 | 0.12 | 0.14 | 0.16 |
| Net Income Per Share | -0.02 | 0.03 | -0.00 | 0.01 | 0.01 |
| Tax Burden | 0.98 | 0.96 | 1.00 | 0.96 | 0.50 |
| Interest Burden | 1.70 | 0.80 | -0.05 | 0.71 | 0.67 |
| Research & Development to Revenue | 0.13 | 0.08 | 0.12 | 0.09 | 0.06 |
| SG&A to Revenue | 0.49 | 0.35 | 0.40 | 0.26 | 0.23 |
| Stock-Based Compensation to Revenue | 0.03 | 0.03 | 0.04 | 0.03 | 0.02 |
| Income Quality | 0.04 | 1.24 | 27.72 | 1.94 | 0.65 |
Currency in CAD

